%20Ltd./other/Syncom_Formulations_India_Ltd.-logo.png){kind=logo}
Syncom Formulations (India) Ltd. — Investor Relations & Filings
Syncom Formulations (India) Ltd. is a pharmaceutical organization specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company maintains an extensive portfolio of over 400 products across various therapeutic categories, including analgesics, antibiotics, anti-infectives, and nutritional supplements. Its manufacturing capabilities encompass multiple dosage forms such as tablets, capsules, liquid orals, dry syrups, and topical preparations. Operating from a WHO-GMP certified facility, the company serves both domestic and international markets, exporting products to numerous countries across the globe. In addition to its proprietary brands, the company provides contract manufacturing services to global pharmaceutical entities, leveraging its technical expertise and quality-driven production processes to meet international standards.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Disclosure under SEBI Takeover Regulations | 2025-06-25 | English | |
| Trading Window | 2025-06-25 | English | |
| Disclosure under SEBI Takeover Regulations | 2025-06-18 | English | |
| General Updates | 2025-06-12 | English | |
| Copy of Newspaper Publication | 2025-05-20 | English | |
| Outcome of Board Meeting | 2025-05-19 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42333870 | Disclosure under SEBI Takeover Regulations | 2025-06-25 | English | ||
| 42340441 | Trading Window | 2025-06-25 | English | ||
| 42324885 | Disclosure under SEBI Takeover Regulations | 2025-06-18 | English | ||
| 42319542 | General Updates | 2025-06-12 | English | ||
| 42387022 | Copy of Newspaper Publication | 2025-05-20 | English | ||
| 42400169 | Outcome of Board Meeting | 2025-05-19 | English | ||
| 43922619 | Board Meeting — Financial Results/Other business matters | 2025-05-13 | English | ||
| 43922593 | Board Meeting — Board Meeting Intimation | 2025-05-13 | English | ||
| 42368635 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-04-17 | English | ||
| 42399786 | General Updates | 2025-04-05 | English | ||
| 42408613 | Trading Window | 2025-03-25 | English | ||
| 42411156 | Updates | 2025-03-05 | English | ||
| 42433357 | Disclosure of material issue | 2025-02-13 | English | ||
| 42501600 | Copy of Newspaper Publication | 2025-02-11 | English | ||
| 42534672 | Integrated Filing- Financial | 2025-02-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Syncom Formulations (India) Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60987/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60987 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60987 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60987 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60987}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Syncom Formulations (India) Ltd. (id: 60987)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.